Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches

Abstract

Objective

To evaluate outcomes in opioid exposed neonates (OENs) assessed by the Eat, Sleep, Console (ESC) tool compared to the Finnegan Neonatal Abstinence Scoring System (FNASS).

Methods

Retrospective analysis of a statewide database of OENs from 2017 to 2020 with birthing hospitals classified based on the assessment tool used. Four main outcomes were examined using multivariable and Poisson logistic regression models.

Results

Of 2375 OENs, 42.1% received pharmacotherapy (PT) with a consistent decrease in PT, length of treatment (LOT), and length of stay (LOS) over the study period. There was no change in use of mother’s own milk (MoM). While outcomes were significantly associated with several specific variables, there were no differences in outcomes between assessment methods.

Conclusion

While there was a significant decrease over time in PT, LOT, and LOS, improvements were independent of the assessment tool used and likely related to the increased use of non-pharmacologic care.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Trends over time for short-term outcomes for infants at risk for NOWS, a comparison between the three study groups.

Similar content being viewed by others

Data availability

The dataset used for this study is not publicly available as it contains some identifiable information, but is available from the corresponding author on reasonable request.

References

  1. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates. Accessed 10 Jun 2023.

  2. Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, et al. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022;3:100052.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA. 2021;325:146–55.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Patrick SW, Barfield WD, Poindexter B, Committee on Fetus and Newborn, Committee on Substance Use and Prevention. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020;146:e2020029074.

    Article  PubMed  Google Scholar 

  5. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2:141–58.

    CAS  PubMed  Google Scholar 

  6. Devlin LA, Breeze JL, Terrin N, Pomar EG, Bada H, Finnegan LP, et al. Association of a simplified Finnegan neonatal abstinence scoring Method with the need for pharmacologic treatment for neonatal abstinence syndrome. JAMA Netw Open. 2020;3:e202275.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr. 2018;8:1–6.

    Article  PubMed  Google Scholar 

  8. Wachman EM, Houghton M, Melvin P, Isley BC, Murzycki J, Singh R, et al. A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care method in Massachusetts’ PNQIN collaborative. J Perinatol. 2020;40:1560–9.

    Article  CAS  PubMed  Google Scholar 

  9. Young LW, Ounpraseuth ST, Merhar SL, Hu Z, Simon AE, Bremer AA et al. ACT NOW Collaborative. Eat, sleep, console approach or usual care for neonatal opioid withdrawal. N Engl J Med. 2023;388:2326–37.

  10. Singh R, Houghton M, Melvin P, Wachman EM, Diop H, Iverson R, et al. Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database. J Perinatol. 2021;41:1381–8.

    Article  CAS  PubMed  Google Scholar 

  11. Singh R, Rothstein R, Ricci K, Vistainer P, Shenberger J, Attwood E, et al. Partnering with parents to improve outcomes for substance exposed newborns—a pilot program. J Perinatol. 2020;40:1041–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kilpatrick SJ, Papile LA, Macones GA. Organization of perinatal healthcare. In: Guidelines for Perinatal Care. 8th Edition:1-36. American Academy of Pediatrics and American College of Obstetrics and Gynecology; 2017.

  13. https://matracking.ehs.state.ma.us/eohhs_regions/eohhs_regions.html. Accessed 10 Aug 2023.

  14. Pregnancy to Early Life Longitudinal Data System (PELL). NAS Dashboard New Data v6a - 2023-02-21 - MHT (mass.gov). Accessed 10 Aug 2023 https://www.mass.gov/info-details/neonatal-abstinence-syndrome-nas-data.

  15. Jilani SM, Jordan CJ, Jansson LM, Davis JM. Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review. J Perinatol. 2021;41:1364–71.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jilani SM, Jones HE, Davis JM. Implementation of a standardized clinical definition of opioid withdrawal in the neonate: challenges and opportunities. JAMA. 2022;327:1643–4.

    Article  PubMed  Google Scholar 

  17. Jones HE, Kaltenbach K, Heil SH, Stein S. M., Coyle M. G., Arria A. M. et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N. Engl J Med. 2010;363:2320–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Singh R, Davis JM. Escaping the Finnegan - Is it time? Semin Fetal Neonatal Med. 2021;26:101218.

    Article  PubMed  Google Scholar 

  19. Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, et al. Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome. J Pediatr. 2020;219:146–51.e1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jones H, Baer G, Davis JM. Neonatal Abstinence Syndrome. In: Boardman JP, Groves A, Ramasethu J editors. Avery and MacDonald’s Neonatology, Pathophysiology and Management of the Newborn, 8th edition, J.B. Lippincott Co., Philadelphia, PA, 2021

  21. Pahl A, Young L, Buss-Frank ME, Marcellus L, Soll R. Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database of Systematic Reviews 2020, Art. No. : CD013217. Accessed Oct 31 2023.

  22. Morrison TM, MacMillan KDL, Melvin P, Singh R, Murzycki J, VanVleet MW, et al. Neonatal opioid withdrawal syndrome: a comparison of as-needed pharmacotherapy. Hosp Pediatr. 2022;12:530–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the contributions of their subjects, and their subjects’ families, as well as those of their colleagues. PNQIN Perinatal Opioid Project Collaborating Hospitals: Baystate Medical Center, Springfield, MA, USA; Baystate Franklin Medical Center, Greenfield, MA, USA; Berkshire Medical Center, Pittsfield, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA; Beverly Hospital, Beverly, MA, USA; Boston Medical Center, Boston, MA, USA; Brockton Hospital, Brockton, MA, USA; Cape Cod Hospital, Hyannis, MA, USA; Cooley-Dickenson Hospital, Northampton, MA, USA; Lowell General Hospital, Lowell, MA, USA; Massachusetts General Hospital, Boston, MA, USA; MelroseWakefield Hospital, Melrose MA, USA; Mercy Medical Center, Springfield, MA, USA; Southcoast Health, Wareham, MA, USA; South Shore Hospital, South Weymouth, MA, USA; Tufts Medical Center, Boston, MA, USA; UMass Memorial Medical Center, Worcester, MA, USA.

Funding

This work has been supported by programmatic funding from Health Policy Commission of Massachusetts.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

RS and JD drafted the original manuscript and conceived and designed the study, contributed to data acquisition and analysis, and drafted the manuscript. PM contributed to data analysis; critically reviewed and revised the manuscript for intellectual content. EW, RR, DS, JM, MVV and MG contributed to data acquisition and analysis; critically reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Rachana Singh.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, R., Melvin, P., Wachman, E.M. et al. Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches. J Perinatol (2024). https://doi.org/10.1038/s41372-024-01953-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41372-024-01953-z

Search

Quick links